Nepafenac | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Nepafenac
Health Canada Patents

Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

Contact Supplier

Evonik

Contact Supplier

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

xyz-pharma-m-2025-02-24

Contact Supplier

Nepafenac

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

22 API Suppliers, 9 USDMF, 1 JDMF, 6 EU WC, 11 NDC API, 14 Listed Suppliers, $ API Reference Price

22 API Suppliers
9 USDMF
1 JDMF
6 EU WC
11 NDC API
14 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

2 Drugs in Development

2 Drugs in Development

FINISHED DOSAGE FORMULATIONS

21 FDF Dossiers, 2 FDA Orange Book, 10 Europe, 2 Canada, 2 South Africa, 5 Listed Dossiers

21 FDF Dossiers
2 FDA Orange Book
10 Europe
2 Canada
2 South Africa
5 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OPHTHALMIC - 0.3%, SUSPENSION/DROPS;OPHTHALMIC - 0.1%

SUSPENSION/DROPS;OPHTHALMIC - 0.3%
SUSPENSION/DROPS;OPHTHALMIC - 0.1%

RELATED EXCIPIENT COMPANIES

3 Rochem International Inc, 13 SPI Pharma, 2 DKSH, 1 Faran Shimi Pharmaceutical, 2 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 5 Actylis, 2 BASF, 1 Curia, 2 Finar, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 2 Kerry, 1 Kima Chemical, 5 Microlex e.U, 1 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 3 Sigachi Industries, 1 The Dow Chemical Company, 1 Valens Pharmachem

3 Rochem International Inc
13 SPI Pharma
2 DKSH
1 Faran Shimi Pharmaceutical
2 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
5 Actylis
2 BASF
1 Curia
2 Finar
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
2 Kerry
1 Kima Chemical
5 Microlex e.U
1 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
3 Sigachi Industries
1 The Dow Chemical Company
1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

20 Fillers, Diluents & Binders, 12 Chewable & Orodispersible Aids, 11 Taste Masking, 10 Direct Compression, 10 Thickeners and Stabilizers, 9 Solubilizers, 9 Parenteral, 9 Disintegrants & Superdisintegrants, 5 Co-Processed Excipients, 4 Topical, 4 Rheology Modifiers, 3 Granulation, 3 Film Formers & Plasticizers, 2 Coating Systems & Additives, 1 API Stability Enhancers, 1 Emulsifying Agents

20 Fillers, Diluents & Binders
12 Chewable & Orodispersible Aids
11 Taste Masking
10 Direct Compression
10 Thickeners and Stabilizers
9 Solubilizers
9 Parenteral
9 Disintegrants & Superdisintegrants
5 Co-Processed Excipients
4 Topical
4 Rheology Modifiers
3 Granulation
3 Film Formers & Plasticizers
2 Coating Systems & Additives
1 API Stability Enhancers
1 Emulsifying Agents

DIGITAL CONTENT

8 NEWS #PharmaBuzz

8 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 9 Regulatory FDF Prices

2 US Medicaid Prescriptions
9 Regulatory FDF Prices

MARKET PLACE

5 APIs, 1 FDF Dossiers

5 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

5 US Patents, 4 Health Canada Patents

5 US Patents
4 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 Others

3 Others

$ API Ref.Price (USD/KG) : 17,193 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

4 All

01 2Alcon Canada Inc.

02 2Gowling WLG (Canada) LLP

filter Patent Reset all filters

4 All

01 22167524

02 12586807

03 12781254

filter Product Reset all filters

4 All

01 4Nepafenac

filter Dosage Reset all filters

4 All

01 2Suspension

02 2suspension

filter Exp Date Reset all filters

4 All

01 22015-06-06

02 12025-12-02

03 12030-12-01

Product Main Page

01

Alcon Canada Inc.

Nepafenac

Pittcon 2025

Not Confirmed

Alcon Canada Inc.

Pittcon 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-06-06

Date Granted : 2002-08-13

Brand Name : NEVANAC

Patent Number : 2167524

Filing Date : 1995-06-06

Strength per Unit : 0.1% (w / v)

Dosage Form : suspension

Human Or VET : Human

Route of Administration : ophthalmic

Patent Expiration Date : 2015-06-06

Date Granted : 2002-08-13

Portfolio PDF

Product Web Link

Digital Content

02

Alcon Canada Inc.

Nepafenac

Pittcon 2025

Not Confirmed

Alcon Canada Inc.

Pittcon 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2015-06-06

Date Granted : 2002-08-13

Brand Name : ILEVRO

Patent Number : 2167524

Filing Date : 1995-06-06

Strength per Unit : 0.3% (w / v)

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2015-06-06

Date Granted : 2002-08-13

Portfolio PDF

Product Web Link

Digital Content

03

Gowling WLG (Canada) LLP

Nepafenac

Pittcon 2025

Not Confirmed

Gowling WLG (Canada) LLP

Pittcon 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-02

Date Granted : 2013-01-29

Brand Name : NEVANAC

Patent Number : 2586807

Filing Date : 2005-12-02

Strength per Unit : 0.1% (w / v)

Dosage Form : suspension

Human Or VET : Human

Route of Administration : ophthalmic

Patent Expiration Date : 2025-12-02

Date Granted : 2013-01-29

Portfolio PDF

Product Web Link

Digital Content

04

Gowling WLG (Canada) LLP

Nepafenac

Pittcon 2025

Not Confirmed

Gowling WLG (Canada) LLP

Pittcon 2025

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2030-12-01

Date Granted : 2016-06-28

Brand Name : ILEVRO

Patent Number : 2781254

Filing Date : 2010-12-01

Strength per Unit : 0.3% (w / v)

Dosage Form : Suspension

Human Or VET : Human

Route of Administration : Ophthalmic

Patent Expiration Date : 2030-12-01

Date Granted : 2016-06-28

Portfolio PDF

Product Web Link

Digital Content

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!